Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of August 2026

  1. Design Therapeutics, Inc.

    World Rank (Aug-2026)
    9,579
    Market Cap (Aug-2026)
    0.928 Billion USD
    World Rank (Jan-05-2024)
    19,654
    Market Cap (Jan-05-2024)
    0.143 Billion USD
    World Rank (Jul-30-2023)
    11,986
    World Rank (Dec-25-2022)
    11,986
    Market Cap (Dec-25-2022)
    0.533 Billion USD
    World Rank (Jan-07-2022)
    9,455
    Market Cap (Jan-07-2022)
    1.00 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -79 Million USD
    Annual Net Income in USD
    -70 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Design Therapeutics, INC is a biotechnology company focused on molecules are designed to selectively bind to genetic repeat sequences, modulate gene expression either by restoring or blocking transcription and restore cellular health. The headquarters is in USA.
  2. Collegium Pharmaceutical

    World Rank (Aug-2026)
    9,617
    Market Cap (Aug-2026)
    0.919 Billion USD
    World Rank (Jan-05-2024)
    8,100
    Market Cap (Jan-05-2024)
    1.103 Billion USD
    World Rank (Jul-30-2023)
    10,025
    Market Cap (Jul-30-2023)
    0.785 Billion USD
    World Rank (Dec-25-2022)
    9,777
    Market Cap (Dec-25-2022)
    0.771 Billion USD
    World Rank (Jan-07-2022)
    11,744
    Market Cap (Jan-07-2022)
    0.66 Billion USD
    Annual Revenue in USD
    781 Million USD
    Annual Operating Income in USD
    180 Million USD
    Annual Net Income in USD
    63 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Collegium Pharmaceutical is a Specialty Pharmaceutical company committed to being the leader in responsible pain management. It has been focused on developing and commercializing new medicines for pain management that reflect its core values and commitment to people suffering from pain, providers and communities. The headquarters is in USA.

  3. Pacira Biosciences

    World Rank (Aug-2026)
    9,625
    Market Cap (Aug-2026)
    0.917 Billion USD
    World Rank (Jan-05-2024)
    6,744
    Market Cap (Jan-05-2024)
    1.506 Billion USD
    World Rank (Jul-30-2023)
    6,485
    Market Cap (Jul-30-2023)
    1.645 Billion USD
    World Rank (Dec-25-2022)
    5,773
    Market Cap (Dec-25-2022)
    1.820 Billion USD
    World Rank (Jan-07-2022)
    5,267
    Market Cap (Jan-07-2022)
    2.67 Billion USD
    Annual Revenue in USD
    726 Million USD
    Annual Operating Income in USD
    19 Million USD
    Annual Net Income in USD
    7 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Pacira BioSciences is a Pharmaceutical company. It is the organization built on high ethical standards an unwavering commitment to patients and transparent communications and have a drive and a desire to improve the world around and make a meaningful difference in the lives of patients, families, communities and society. The headquarters is in USA.
  4. Amphastar Pharmaceuticals

    World Rank (Aug-2026)
    9,798
    Market Cap (Aug-2026)
    0.889 Billion USD
    World Rank (Jan-05-2024)
    4,332
    Market Cap (Jan-05-2024)
    3.040 Billion USD
    World Rank (Jul-30-2023)
    4,422
    Market Cap (Jul-30-2023)
    2.937 Billion USD
    World Rank (Dec-25-2022)
    6,890
    Market Cap (Dec-25-2022)
    1.386 Billion USD
    World Rank (Jan-07-2022)
    8,516
    Market Cap (Jan-07-2022)
    1.20 Billion USD
    Annual Revenue in USD
    720 Million USD
    Annual Operating Income in USD
    140 Million USD
    Annual Net Income in USD
    98 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Amphastar Pharmaceuticals is a Specialty Pharmaceutical company that is engaged in the development, manufacture and marketing of generic and proprietary injectable, intranasal and inhalation products. It produce over 20 commercial products while continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. The headquarters is in USA.
  5. Theravance Biopharma

    World Rank (Aug-2026)
    9,844
    Market Cap (Aug-2026)
    0.881 Billion USD
    World Rank (Jan-05-2024)
    11,722
    Market Cap (Jan-05-2024)
    0.577 Billion USD
    World Rank (Jul-30-2023)
    11,975
    Market Cap (Jul-30-2023)
    0.565 Billion USD
    World Rank (Dec-25-2022)
    9,878
    Market Cap (Dec-25-2022)
    0.761 Billion USD
    World Rank (Jan-07-2022)
    9,685
    Market Cap (Jan-07-2022)
    0.96 Billion USD
    Headquarters Country
  6. Candel Therapeutics Inc.

    World Rank (Aug-2026)
    9,953
    Market Cap (Aug-2026)
    0.859 Billion USD
    World Rank (Jan-05-2024)
    25,557
    Market Cap (Jan-05-2024)
    0.044 Billion USD
    World Rank (Jul-30-2023)
    27,650
    Market Cap (Jul-30-2023)
    0.030 Billion USD
    World Rank (Dec-25-2022)
    25,831
    Market Cap (Dec-25-2022)
    0.044 Billion USD
    World Rank (Jan-07-2022)
    19,243
    Market Cap (Jan-07-2022)
    0.19 Billion USD
    Annual Operating Income in USD
    -48 Million USD
    Annual Net Income in USD
    -38 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
  7. Aclaris Therapeutics

    World Rank (Aug-2026)
    9,990
    Market Cap (Aug-2026)
    0.851 Billion USD
    World Rank (Jan-05-2024)
    22,560
    Market Cap (Jan-05-2024)
    0.080 Billion USD
    World Rank (Jul-30-2023)
    10,734
    Market Cap (Jul-30-2023)
    0.694 Billion USD
    World Rank (Dec-25-2022)
    8,331
    Market Cap (Dec-25-2022)
    1.006 Billion USD
    World Rank (Jan-07-2022)
    10,798
    Market Cap (Jan-07-2022)
    0.78 Billion USD
    Annual Revenue in USD
    8 Million USD
    Annual Operating Income in USD
    -76 Million USD
    Annual Net Income in USD
    -65 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country

Share

Ads